Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions are reported for this page.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, superseding the previous v3.6.5. This appears to be an administrative/quality-control update to the record rather than a change to study data or public content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.4 to v3.6.5 to reflect the latest version of the record.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision tag v3.6.4 was added to the study record history, and the previous revision tag v3.6.3 was removed. This reflects an update to the page's versioning metadata within the record history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study record history now shows the latest revision as v3.6.3, replacing the prior v3.6.2 in the version history.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's history, and the previous revision (v3.6.0) was removed from the history, indicating a version update to the page.SummaryDifference0.1%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.